Featured Research

from universities, journals, and other organizations

New Anti-cancer Agent Can Overcome Resistance To Drugs, Says Study

Date:
February 25, 2008
Source:
Imperial College London
Summary:
A new anti-cancer agent that targets breast cancer can overcome resistance to cancer drugs, according to a new study. Many tumours that are initially responsive to chemotherapy can develop resistance to it, allowing the cancer to progress. Studies have shown that one of the key reasons for the development of resistance is a protein pump called P-glycoprotein. Resistant cancer cells express P-glycoprotein and this removes anti-cancer drugs from the cell before they are able to kill the cell.

A new anti-cancer agent that targets breast cancer can overcome resistance to cancer drugs, according to a new study.
Credit: iStockphoto

A new anti-cancer agent that targets breast cancer can overcome resistance to cancer drugs, according to a new study. Many tumours that are initially responsive to chemotherapy can develop resistance to it, allowing the cancer to progress. Studies have shown that one of the key reasons for the development of resistance is a protein pump called P-glycoprotein. Resistant cancer cells express P-glycoprotein and this removes anti-cancer drugs from the cell before they are able to kill the cell.

Related Articles


The new study shows that P-glycoprotein is not able to remove a recently identified anti-cancer agent known as STX140 from cancer cells. STX140 works by stimulating a natural cell suicide process and is able to kill cancer cells which express the P-glycoprotein pump.

For the new study, mice with drug-resistant tumours were given either STX140 or a currently used clinical drug, Taxol, for 28 days. The drug-resistant tumours shrank in size in response to STX140 whereas the drug-resistant tumours treated with Taxol continued to increase in size.

Dr Simon Newman, lead author of the paper* from the Oncology Drug Discovery and Women's Health Group at Imperial College London, said: "Whilst the research is still at a very early stage the results of our studies show that STX140 may, in the future, have a role to play in difficult to treat advanced drug-resistant breast cancer.

"STX140 is potentially a very exciting new drug as it may be given by the oral route at regular intervals, and, as this new study has shown, it can target tumours which are resistant to many currently used anti-cancer drugs. However, before STX140 can progress to the clinic numerous further studies will have to be undertaken to ensure the safety of this exciting compound," Added Dr Newman.

*Journal reference: Clinical Cancer Research 2008 Jan 15; 14(2): 597-606.


Story Source:

The above story is based on materials provided by Imperial College London. Note: Materials may be edited for content and length.


Cite This Page:

Imperial College London. "New Anti-cancer Agent Can Overcome Resistance To Drugs, Says Study." ScienceDaily. ScienceDaily, 25 February 2008. <www.sciencedaily.com/releases/2008/02/080221093550.htm>.
Imperial College London. (2008, February 25). New Anti-cancer Agent Can Overcome Resistance To Drugs, Says Study. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2008/02/080221093550.htm
Imperial College London. "New Anti-cancer Agent Can Overcome Resistance To Drugs, Says Study." ScienceDaily. www.sciencedaily.com/releases/2008/02/080221093550.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins